Terapia con medicamentos por hipo

Marion Debus

Última actualización: 11.01.2022

Los medicamentos centrales en el tratamiento del hipo persistente son cobre, como metal que fomenta el calor y la relajación, así como preparados vegetales de la familia de las solanáceas, en especial Nicotiana tabacum (antiespasmódica) e Hyoscyamus niger (ritmizante y calmante):

Aurum/Hyoscyamus comp. WELEDA

Cuprum aceticum comp. WALA
o
Cuprum aceticum D4 WELEDA, 1 amp. s.c. sobre el epigastrio
o
Cuprum aceticum D5/Zincum Valerianicum D5 WELEDA, 1 amp. s.c. varias veces

También entran en consideración:
Tabacum Cupro cultum Rh D3 WELEDA, 1 amp. s.c. en el epigastrio

Para aumentar el efecto de las inyecciones combinar con:
Nervus phrenicus D15 – D30 WALA, 1 amp. x día s.c. 3 x semana

Oralmente se toman en consideración: 
Hyoscyamus Rh D3 Dil. WELEDA, 10 gotas 3 x día
o
Hyoscyamus D6 glob. WALA, 7 glób. cada 1 – 2 horas
o en combinación con
Mygale comp. Dil. WELEDA, 5 – 10 gotas cada 1 – 2 horas

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degreee of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. These findings may underline the clinical impact of add-on VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers:  
https://doi.org/10.3390/cancers16081609.